ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

23 hedge funds and large institutions have $7.1M invested in Oncternal Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.04M
2
+$331K
3
+$135K
4
AC
Armistice Capital
New York
+$101K
5
Morgan Stanley
Morgan Stanley
New York
+$9.43K

Top Sellers

1
-$10.5K
2
-$6K
3
-$5.86K
4
BlackRock
BlackRock
New York
-$1.16K
5
Millennium Management
Millennium Management
New York
-$46
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.24M
2
$2.04M
3
$829K
4
$473K
5
$331K
6
$256K
7
$251K
8
$144K
9
$123K
10
$119K
11
$110K
12
$46K
13
$32K
14
$30K
15
$26K
16
$22K
17
$10K
18
$7K
19
$7K
20
$2K
21
$60
22
–